abstract |
The present invention relates to methods and pharmaceutical compositions for treating or slowing the progression of a cancer, namely pancreatic cancer or esophageal cancer, comprising administering to a human subject in need thereof a quantity of therapeutically effective histone methyltransferase inhibitor, SETD2. |